Lukas Šimas specializes in all aspects of antitrust and competition laws, as well as related EU regulatory matters.
He represents clients in complex merger proceedings before the European Commission and other competition authorities worldwide, as well as advises companies and individuals in global cartel investigations (adverse and settlement procedures). Lukas’ practice covers a broad range of industry sectors, including electronics, energy, investment management, medical devices, pharmaceuticals, and transportation. He also advises clients in internal and other government investigations worldwide.
Before joining Arnold & Porter in 2021, Lukas was an associate at another major U.S. law firm in Brussels. Prior to that, he worked as a summer associate in a capital markets and derivatives department at an international law firm in London, and in a corporate and M&A department at a pan-Baltic law firm in Vilnius, Lithuania. He also worked as an in-house lawyer in the legal department of a medical devices distributor, where his work covered public procurement and antitrust issues.
Experience
- Novo Nordisk in obtaining merger control and regulatory approvals in connection with its US$11 billion acquisition of three fill-finish sites from Novo Holdings A/S (Novo Holdings). As part of the deal, valued at US$16.5 billion, Novo Holdings acquired Catalent.
- Pfizer in obtaining global merger control clearances in relation to its US$6.7 billion acquisition of Arena Pharmaceuticals.
- Pfizer in obtaining global merger control and FDI clearances in relation to its US$43 billion acquisition of Seagen.
- Baker Hughes in connection with its US$32 billion combination with General Electric Oil & Gas.*
- Baker Hughes in the creation of an aero-derivative joint venture with General Electric after Baker Hughes separated from General Electric.*
- Baker Hughes in the creation of a joint venture with Akastor, which combined Baker Hughes' Subsea Drilling Systems business with Akastor’s wholly owned subsidiary, MHWirth, to deliver global offshore drilling solutions.*
- Danaher in its US$21.4 billion acquisition of General Electric Healthcare Life Sciences’ biopharma business.*
- Private equity firm in a bid for US$6 billion divestment proposed by the merging parties in the Praxair/Linde EU Phase II merger.*
* Experience gained prior to Arnold & Porter
Perspectives
Credentials
Education
- M.Sc., Taxation, University of Oxford, Christ Church, 2022, Law Faculty Prize in Transfer Pricing
- LL.M., University of California, Berkeley, 2016, Best Written Brief Award
- LL.M., University College London, 2015
- LL.B., University of Exeter, 2014
Admissions
- Brussels, Belgium (EU-list)
- New York
- Roll of Solicitors in England and Wales
- Roll of Solicitors in Ireland